RASHMIKABEN PATEL: Open Payments
NPI 1083221022 · ALGONQUIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $294 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55 |
| Astellas Pharma US Inc | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
| ABBVIE INC. | 1 | $17 |
| Orexo US, Inc. | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: JARDIANCE, Veozah, MOUNJARO, CAPLYTA, Cologuard Collection Kit, VRAYLAR, Zubsolv, ELIQUIS.
Industry payments across IL — which companies pay providers there.
